We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot). You can revoke your voluntary consent at any time. You can find further information and setting options under „Configure“ and in our data protection information.
ELEKTA'S SHARE REDEMPTION PROGRAM CONCLUDED
On November 11, 2003, the acceptance period for Elekta's offer for
redemption of shares expired.
The offer involved redemption of every seventeenth share held in Elekta
at a price of SEK 165 per share.
Based on the final count, 1,887,713 shares were tendered for redemption,
corresponding to 97.4 percent of the maximum number of shares that could
be redeemed in accordance with the offer. Approx. SEK 311.5 million will
thus be transferred to Elekta's shareholders.
Payment of the redemption amount is expected to be made at the end of
March 2004. This is caused by the fact that under Swedish law, when a
company decides to redeem shares by reducing the share capital, the
decision may not be effected without the permission of a Swedish court.
It is estimated that the court's permission will be obtained within 3-4
months from the end of the application period and that payment of the
redemption proceeds will occur as soon as reasonably practicable after
the court's permission has gained legal force.
Elekta is a world-leading supplier of advanced and innovative radiationoncology and neurosurgery solutions and services for precise treatmentof cancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.For additional information about Elekta, please visit www.elekta.comThis information was brought to you by Waymaker http://www.waymaker.netThe following files are available for download:http://www.waymaker.net/bitonline/2003/11/14/20031114BIT00150/wkr0001.dochttp://www.waymaker.net/bitonline/2003/11/14/20031114BIT00150/wkr0002.pdf